# Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome

> **NCT06361004** · NA · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 60 (estimated)

## Conditions studied

- Tourette's Syndrome

## Interventions

- **DEVICE:** Deep Brain Stimulation (DBS)

## Key facts

- **NCT ID:** NCT06361004
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-20
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06361004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06361004, "Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06361004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*